RISK FACTORS FOR OOCYTE DYSMORPHISMS IN ASSISTED REPRODUCTIVE TECHNOLOGY PROGRAMS
- Авторлар: Gorshkova A.G.1, Dolgushina N.V.1, Makarova N.P.1, Kovalskaya E.V.1, Kalinina E.A.1
-
Мекемелер:
- Academician V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
- Шығарылым: № 5 (2015)
- Беттер: 66-73
- Бөлім: Articles
- URL: https://journals.eco-vector.com/0300-9092/article/view/247415
- ID: 247415
Дәйексөз келтіру
Аннотация
Толық мәтін
![Рұқсат жабық](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_lock.png)
Авторлар туралы
Anastasia Gorshkova
Academician V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
Email: a_gorshkova@oparina4.ru
M.D., Postgraduate of the Department of assistive reproductive technology in the treatment of infertility Moscow 117997, Ac. Oparina str. 4, Russia
Nataliya Dolgushina
Academician V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
Email: n_dolgushina@oparina4.ru
M.D., Ph.D., M.P.H., Head of R&D Department Moscow 117997, Ac. Oparina str. 4, Russia
Nataliya Makarova
Academician V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
Email: np_makarova@oparina4.ru
PhD, Researcher of the Department of assistive reproductive technology in the treatment of infertility Moscow 117997, Ac. Oparina str. 4, Russia
Evgeniya Kovalskaya
Academician V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
Email: e_kovalskaya@oparina4.ru
embryologist of the Department of assistive reproductive technology in the treatment of infertility Moscow 117997, Ac. Oparina str. 4, Russia
Elena Kalinina
Academician V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
Email: e_kalinina@oparina4.ru
M.D., Ph.D., Head of the Department of assistive reproductive technology in the treatment of infertility Moscow 117997, Ac. Oparina str. 4, Russia
Әдебиет тізімі
- Rienzi L., Ubaldi F.M., Iacobelli M., Minasi M.G., Romano S., Ferrero S. et al. Significance of metaphase II human oocyte morphology on ICSI outcome. Fertil. Steril. 2008; 90(5): 1692-700.
- Ubaldi F., Rienzi L. Morphological selection of gametes. Placenta. 2008; 10: 115-20.
- Ten J., Mendiola J., de Juan J., Bernabeu R. Donor oocyte dysmorphisms and their influence on fertilization and embryo quality. Reprod. Biomed. Online. 2007; 14: 40-8.
- Wilding M., Di Matteo L., D’Andretti S., Montanaro N., Capobianco C., Dale B. An oocyte score for use in assisted reproduction. J. Assist. Reprod. Genet. 2007; 24(8): 350-8.
- Balakier H., Sojeck A., Gelareh M., Siamak B. Is the zona pellucida thickness of human embryos influenced by women’s age and hormonal levels ? Fertil. Steril. 2012; 98(1): 77-83.
- Setti A.S., Braga D.P., Figueira Rde C., Vingris L., Iaconelli A., Borges E. Jr. Body mass index is negatively correlated with the response to controlled ovarian stimulation but does not influence oocyte morphology in ICSI cycles. Eur. J. Obstet. Gynecol. Reprod. Biol. 2012; 163(2): 175-9.
- Ebner T., Sommergruber M., Moser M., Shebl O., Tews G. Basal level of anti-Müllerian hormone is associated with oocyte quality in stimulated cycles. Hum. Reprod. 2006; 21(8): 2022-6.
- Cota A.M., Oliveira J.B., Petersen C.G., Mauri A.L., Massaro F.C., Silva L.F. et al. GnRH agonist versus GnRH antagonist in assisted reproduction cycles : oocyte morphology. Reprod. Biol. Endocrinol. 2012; 10: 33.
- Fancsovits P., Tóthné Z.G., Murber Á., Rigó J., Urbancsek J. Importance of cytoplasmic granularity of human oocytes in in vitro fertilization treatments. Acta Biol. Hung. 2012; 63(2): 189-201.
- Yoldemir T. Does the duration of gonadotropin stimulation affect embryo quality on post-retrieval day 3? Gynecol. Endocrinol. 2011; 27(5): 324-30.
- Приказ Минздрава России №107н от 30 августа 2012 г. «О порядке использования вспомогательных репродуктивных технологий, противопоказаниях и показаниях к их применению».
- Kuliev A., Cieslak J., Ilkevitch Y., Verlinsky Y. Chromosomal abnormalities in a series of 6733 human oocytes in preimplantation diagnosis for age-related aneuploidies. Reprod. Biomed. Online. 2003; 6(1): 54-9.
- Schmutzler A.G., Acar-Perk B., Weimer J., Salmassi A., Sievers K., Tobler M. et al. Oocyte morphology on day 0 correlates with aneuploidy as detected by polar body biopsy and FISH. Arch. Gynecol. Obstet. 2014; 289(2): 445-50.
- Robker R.L., Wu L.L., Yang X. Inflammatory pathways linking obesity and ovarian dysfunction. J. Reprod. Immunol. 2011; 88(2): 142-8.
- Yilmaz N., Kilic S., Kanat-Pektas M., Gulerman C., Mottamahmutoglu L. The relationship between obesity and fecundity. J.Women’s Health. (Larchmt). 2009; 18(5): 633-6.
- Acevedo B., Gomez-Palomares J.L., Ricciarelli E., Hernández E.R. Triggering ovulation with gonadotropin-releasing hormone agonists does not compromise embryo implantation rates. Fertil. Steril. 2006; 86(6): 1682-7.
- Engmann L., DiLuigi A., Schmidt D., Nulsen J., Maier D., Benadiva C. The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte matura tion after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study. Fertil. Steril. 2008; 89(1): 84-91.
Қосымша файлдар
![](/img/style/loading.gif)